西司他丁通过抑制megalin改善横纹肌溶解诱导的急性肾损伤
该研究在雄性C57BL/6小鼠中采用甘油注射诱导横纹肌溶解模型,发现近端小管特异性敲除megalin可保护肾功能、减少小管损伤和凋亡,并增加尿肌红蛋白清除。给予野生型小鼠药理抑制剂西司他丁可重现上述保护效应,且该效应依赖于megalin。
要点
- 近端小管megalin介导的肌红蛋白内吞是横纹肌溶解性AKI的关键损伤机制。
- 西司他丁通过抑制megalin减少小管肌红蛋白摄取,改善肾功能和结构损伤。
- megalin抑制可能成为横纹肌溶解相关AKI的潜在药物治疗靶点。
核心结论
- megalin在横纹肌溶解诱导的AKI中起关键作用,干扰或抑制megalin可改善该损伤。
研究设计与样本
- 研究使用雄性C57BL/6小鼠及近端小管特异性megalin敲除小鼠(14-32周龄),采用水剥夺后注射50%甘油生理盐水的横纹肌溶解模型。
主要发现
- 诱导性近端小管特异性敲除megalin在横纹肌溶解性AKI模型中具有高度保护作用。
- megalin敲除小鼠在损伤后24小时保持GFR、减少近端小管损伤(以KIM-1为指标)和肾脏凋亡,并增加尿肌红蛋白清除。
- 与同窝对照相比,megalin缺陷小鼠未出现进行性GFR下降和持续性新发蛋白尿。
- 给予野生型小鼠药理megalin抑制剂西司他丁可重现megalin敲除的肾脏保护效应,且该效应依赖于megalin。
- 西司他丁引起选择性蛋白尿和抑制小管肌红蛋白摄取,与megalin敲除类似。
临床怎么用
- 西司他丁等megalin抑制剂可能作为横纹肌溶解相关AKI的潜在治疗选择,但需进一步转化研究验证。
局限性
- 研究仅在小鼠模型中进行,尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rhabdomyolysis, the destruction of skeletal muscle, is a significant cause of AKI and death in the context of natural disaster and armed conflict. Rhabdomyolysis may also initiate CKD. Development of specific pharmacologic therapy is desirable because supportive care is nearly impossible in austere environments. Myoglobin, the principal cause of rhabdomyolysis-related AKI, undergoes megalin-mediated endocytosis in proximal tubule cells, a process that specifically injures these cells. METHODS: To investigate whether megalin is protective in a mouse model of rhabdomyolysis-induced AKI, we used male C57BL/6 mice and mice (14-32 weeks old) with proximal tubule-specific deletion of megalin. We used a well-characterized rhabdomyolysis model, injection of 50% glycerol in normal saline preceded by water deprivation. RESULTS: Inducible proximal tubule-specific deletion of megalin was highly protective in this mouse model of rhabdomyolysis-induced AKI. The megalin knockout mice demonstrated preserved GFR, reduced proximal tubule injury (as indicated by kidney injury molecule-1), and reduced renal apoptosis 24 hours after injury. These effects were accompanied by increased urinary myoglobin clearance. Unlike littermate controls, the megalin-deficient mice also did not develop progressive GFR decline and persistent new proteinuria. Administration of the pharmacologic megalin inhibitor cilastatin to wild-type mice recapitulated the renoprotective effects of megalin deletion. This cilastatin-mediated renoprotective effect was dependent on megalin. Cilastatin administration caused selective proteinuria and inhibition of tubular myoglobin uptake similar to that caused by megalin deletion. CONCLUSIONS: We conclude that megalin plays a critical role in rhabdomyolysis-induced AKI, and megalin interference and inhibition ameliorate rhabdomyolysis-induced AKI. Further investigation of megalin inhibition may inform translational investigation of a novel potential therapy.
引用
- Matsushita K, Mori K, Saritas T, et al. Cilastatin Ameliorates Rhabdomyolysis-induced AKI in Mice. J Am Soc Nephrol. 2021. PMID: 34341182. doi:10.1681/ASN.2020030263
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。